Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by DJDawgon Aug 18, 2023 1:39pm
287 Views
Post# 35595198

RE:RE:RE:RE:RE:RE:share activity

RE:RE:RE:RE:RE:RE:share activityThat makes sense and explains the share price patterns. Just weird doing it when last one was closed June 30.

So for the rest of the longholder who don't get to be part of a PP, we just hold as the selling is not because someone doesn't believe in the science but rather someone(s) is selling to get cash to buy at 0.25 and get a warrant.

It also makes sense that not getting much from these PP's as there was that follow on one late last year and that was very undersubscribed.

RDW really needs to widen the circle of investors invited to the PP's OR look into some license agreement to get some upfront cash. I've said it many times but SESN got a few million just licensing to Turkish pharma. SESN's data was not as good as ours.

So until RDW says that the PP is done done, all longholders should wait and buy selectively only at 0.23 and 0.24. IMO.



<< Previous
Bullboard Posts
Next >>